» Articles » PMID: 21512607

MRI in Patients with Inflammatory Bowel Disease

Overview
Date 2011 Apr 23
PMID 21512607
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammatory bowel disease (IBD) affects ≈1.4 million people in North America and, because of its typical early age of onset and episodic disease course, IBD patients often undergo numerous imaging studies over the course of their lifetimes. Computed tomography (CT) has become the standard imaging modality for assessment of IBD patients because of its widespread availability, rapid image acquisition, and ability to evaluate intraluminal and extraluminal disease. However, repetitive CT imaging has been associated with a significant ionizing radiation risk to patients, making MRI an appealing alternative IBD imaging modality. Pelvic MRI is currently the imaging gold standard for detecting perianal disease, while recent studies indicate that MRI bowel-directed techniques (enteroclysis, enterography, colonography) can accurately evaluate bowel inflammation in IBD. With recent technical innovations leading to faster and higher resolution body MRI, the role of MRI in IBD evaluation is likely to continue to expand. Future applications include surveillance imaging, detection of mural fibrosis, and early assessment of therapy response.

Citing Articles

Predictive Value of FDG Uptake on PET for Future Immune Checkpoint Inhibitor-Mediated Colitis: A Case Series.

Shatila M, Takigawa K, Lu Y, Caleb Urias Rivera A, Mittal N, Aleem A J Clin Med. 2025; 14(1.

PMID: 39797338 PMC: 11721701. DOI: 10.3390/jcm14010256.


Imaging of Ulcerative Colitis: The Role of Diffusion-Weighted Magnetic Resonance Imaging.

Alyami A J Clin Med. 2024; 13(17).

PMID: 39274415 PMC: 11396149. DOI: 10.3390/jcm13175204.


Recent Trends in Non-Invasive Methods of Diagnosis and Evaluation of Inflammatory Bowel Disease: A Short Review.

Valean D, Zaharie R, Taulean R, Usatiuc L, Zaharie F Int J Mol Sci. 2024; 25(4).

PMID: 38396754 PMC: 10889152. DOI: 10.3390/ijms25042077.


Achieving safe and high-performance gastrointestinal tract spectral CT imaging with small-molecule lanthanide complex.

Che X, Yang C, Pan L, Gu D, Dai G, Shu J Biomater Res. 2023; 27(1):119.

PMID: 37990349 PMC: 10664581. DOI: 10.1186/s40824-023-00463-x.


Imaging of Gastrointestinal Tract Ailments.

Sun B, Liu J, Li S, Lovell J, Zhang Y J Imaging. 2023; 9(6).

PMID: 37367463 PMC: 10299193. DOI: 10.3390/jimaging9060115.


References
1.
Paulsen S, Huprich J, Fletcher J, Booya F, Young B, Fidler J . CT enterography as a diagnostic tool in evaluating small bowel disorders: review of clinical experience with over 700 cases. Radiographics. 2006; 26(3):641-57. DOI: 10.1148/rg.263055162. View

2.
Koelbel G, Schmiedl U, Majer M, Weber P, Jenss H, Kueper K . Diagnosis of fistulae and sinus tracts in patients with Crohn disease: value of MR imaging. AJR Am J Roentgenol. 1989; 152(5):999-1003. DOI: 10.2214/ajr.152.5.999. View

3.
Desmond A, ORegan K, Curran C, McWilliams S, Fitzgerald T, Maher M . Crohn's disease: factors associated with exposure to high levels of diagnostic radiation. Gut. 2008; 57(11):1524-9. DOI: 10.1136/gut.2008.151415. View

4.
Del Vescovo R, Sansoni I, Caviglia R, Ribolsi M, Perrone G, Leoncini E . Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease. Abdom Imaging. 2007; 33(4):417-24. DOI: 10.1007/s00261-007-9267-4. View

5.
Masselli G, Casciani E, Polettini E, Gualdi G . Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn's disease. Eur Radiol. 2007; 18(3):438-47. DOI: 10.1007/s00330-007-0763-2. View